State Street Corp Summit Therapeutics Inc. Transaction History
State Street Corp
- $2.36 Trillion
- Q1 2025
A detailed history of State Street Corp transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, State Street Corp holds 4,851,388 shares of SMMT stock, worth $95.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,851,388
Previous 5,602,910
13.41%
Holding current value
$95.6 Million
Previous $100 Million
6.43%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding SMMT
# of Institutions
236Shares Held
86.8MCall Options Held
1.84MPut Options Held
3.13M-
Baker Bros. Advisors LP New York, NY24.4MShares$481 Million5.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.6MShares$229 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$156 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.56MShares$129 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA3.28MShares$64.7 Million0.01% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $3.97B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...